Biobehavioral Intervention for Testicular Cancer
Trial Summary
What is the purpose of this trial?
This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult testicular cancer patients. Participants will be randomized to receive six sessions of GET or Individual Supportive Listening (ISL) delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary (depressive and anxiety symptoms) and secondary (emotion regulation and goal navigation skills, career confusion) psychological outcomes prior to (T0), immediately after (T1), twelve weeks after intervention (T2) and 24 weeks after the intervention (T3). Additionally, identified biomarkers will be measured at baseline and at T1, T2, and T3.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Goal-Focused Emotion-Regulation Therapy (GET) for testicular cancer?
Is Goal-Focused Emotion-Regulation Therapy (GET) safe for humans?
How is the treatment Goal-Focused Emotion-Regulation Therapy (GET) unique for testicular cancer survivors?
Goal-Focused Emotion-Regulation Therapy (GET) is unique because it specifically targets the emotional and goal-related challenges faced by young adult testicular cancer survivors, aiming to improve distress symptoms and emotion regulation while also addressing stress-sensitive biomarkers, which is not commonly the focus of other treatments for this condition.12346
Research Team
Michael A Hoyt, PhD
Principal Investigator
University of California, Irvine
Eligibility Criteria
This trial is for young adults aged 18-39 who have had testicular cancer and finished chemotherapy within the last 4 years. They must be fluent in English or Spanish, feel distressed (scoring >4 on a Distress Thermometer), and be able to consent. It's not for regular smokers, those with immune-affecting conditions, recent heart attacks or strokes, Type I diabetes, acute hepatitis, recent vaccinations, or a history of psychiatric or cognitive disturbances.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive six sessions of Goal-focused Emotion-Regulation Therapy (GET) or Individual Supportive Listening (ISL) over eight weeks
Follow-up
Participants are monitored for psychological and biobehavioral outcomes post-treatment
Treatment Details
Interventions
- Goal-Focused Emotion-Regulation Therapy (GET)
- Individual Supportive Listening
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Memorial Sloan Kettering Cancer Center
Collaborator